CoChat

Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma

Open access
Menotti, Matteo, Ambrogio, Chiara, Cheong, Taek-Chin, Pighi, Chiara, Mota, Ines, Cassel, Seth H., Compagno, Mara, Wang, Qi, Dall’Olio, Riccardo, Minero, Valerio G., Poggio, Teresa, Sharma, Geeta Geeta, Patrucco, Enrico, Mastini, Cristina, Choudhari, Ramesh, Pich, Achille, Zamo, Alberto, Piva, Roberto, Giliani, Silvia, Mologni, Luca, Collings, Clayton K., Kadoch, Cigall, Gambacorti-Passerini, Carlo, Notarangelo, Luigi D., Anton, Ines M., Voena, Claudia, Chiarle, Roberto · 2019 · Nature Medicine
Cited by 76

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

In T lymphocytes, the Wiskott–Aldrich Syndrome protein (WASP) and WASP-interacting-protein (WIP) regulate T cell antigen receptor (TCR) signaling, but their role in lymphoma is largely unknown. Here we show that the expression of WASP and WIP is frequently low or absent in anaplastic large cell lymphoma (ALCL) compared to other T cell lymphomas. In anaplastic lymphoma kinase–positive (ALK+) ALCL, WASP and WIP expression is regulated by ALK oncogenic activity via its downstream mediators STAT3 and C/EBP-β. ALK+ lymphomas were accelerated in WASP- and WIP-deficient mice. In the absence of WASP, active GTP-bound CDC42 was increased and the genetic deletion of one CDC42 allele was sufficient to impair lymphoma growth. WASP-deficient lymphoma showed increased mitogen-activated protein kinase (MAPK) pathway activation that could be exploited as a therapeutic vulnerability. Our findings demonstrate that WASP and WIP are tumor suppressors in T cell lymphoma and suggest that MAP-kinase kinase (MEK) inhibitors combined with ALK inhibitors could achieve a more potent therapeutic effect in ALK+ ALCL. WASP is a novel tumor-suppressor gene in ALK-driven anaplastic large cell lymphoma through modulation of CDC42 and MAPK signaling and provides a rationale for combination therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-018-0262-9

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 76

Metadata

Authors
Menotti, M., Ambrogio, C., Cheong, T.-C., Pighi, C., Mota, I., Cassel, S. H., Compagno, M., Wang, Q., Dall’Olio, R., Minero, V. G., Poggio, T., Sharma, G. G., Patrucco, E., Mastini, C., Choudhari, R., Pich, A., Zamo, A., Piva, R., Giliani, S., Mologni, L., Collings, C. K., Kadoch, C., Gambacorti-Passerini, C., Notarangelo, L. D., Anton, I. M., Voena, C., & Chiarle, R.
Venue
Nature Medicine
Published
2018-12-03
Volume
25
Issue
1
Pages
130-140
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W2901781473
Cited by
76
References
6
FWCI
5.62
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma. https://app.cochat.ai/papers/10.1038/s41591-018-0262-9
The paper
Menotti, M., Ambrogio, C., Cheong, T.-C., Pighi, C., Mota, I., Cassel, S. H., Compagno, M., Wang, Q., Dall’Olio, R., Minero, V. G., Poggio, T., Sharma, G. G., Patrucco, E., Mastini, C., Choudhari, R., Pich, A., Zamo, A., Piva, R., Giliani, S., . . . Chiarle, R. (2019). Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma. Nature Medicine. https://doi.org/10.1038/s41591-018-0262-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.